ArticleEpidemiology and infection2016
Estimating the risk of acute rheumatic fever in New Zealand by age, ethnicity and deprivation.
Article in Epidemiology and infection, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 32 citations in OpenAlex.
- Te Maatai Manawa a Whaanau: Maaori and Pacific People's Experiences of Echocardiography in Rheumatic Fever Health Care in Auckland, New Zealand.Journal of paediatrics and child health · 2026Article
- Article
- Risk Factors for Acute Rheumatic Disease: Exploring Factors at Individual and Collective Levels.Revista da Sociedade Brasileira de Medicina Tropical · 2024Review
- Acute rheumatic fever and rheumatic heart disease in children and adolescents in Victoria, Australia.Journal of paediatrics and child health · 2023Article
- Risk factors for acute rheumatic fever: A case-control study.The Lancet regional health. Western Pacific · 2022Article
- Long-term outcomes following rheumatic heart disease diagnosis in Australia.European heart journal open · 2021Article
- Antibody responses to collagen peptides and streptococcal collagen-like 1 proteins in acute rheumatic fever patients.Pathogens and disease · 2021Article
- Does group A strep have any skin in the ARF game?The Lancet regional health. Western Pacific · 2021Article
- Rising Ethnic Inequalities in Acute Rheumatic Fever and Rheumatic Heart Disease, New Zealand, 2000-2018.Emerging infectious diseases · 2021Article
- Toward the Knowledge of the Epidemiological Impact of Acute Rheumatic Fever in Italy.Frontiers in pediatrics · 2021Article
- Rheumatic heart disease anno 2020: Impacts of gender and migration on epidemiology and management.European journal of clinical investigation · 2020Review
- The use of cardiac valve procedures for rheumatic heart disease in Australia; a cross-sectional study 2002-2017.Annals of medicine and surgery (2012) · 2020Article
- Raising awareness for rheumatic mitral valve disease.Global cardiology science & practice · 2020Article
- COVID-19: we must not forget about Indigenous health and equity.Australian and New Zealand journal of public health · 2020Article
- Distribution of Streptococcal Pharyngitis and Acute Rheumatic Fever, Auckland, New Zealand, 2010-2016.Emerging infectious diseases · 2020Article
- Evaluating Vitamin D levels in Rheumatic Heart Disease patients and matched controls: A case-control study from Nepal.PloS one · 2020Article
- Risk Factors for Acute Rheumatic Fever: Literature Review and Protocol for a Case-Control Study in New Zealand.International journal of environmental research and public health · 2019Review
- Understanding group A streptococcal pharyngitis and skin infections as causes of rheumatic fever: protocol for a prospective disease incidence study.BMC infectious diseases · 2019Article
- Group AInfection and immunity · 2019Article
- Rheumatic Fever in Large Cohort of Adolescents in Israel.Frontiers in medicine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In New Zealand, efforts to control acute rheumatic fever (ARF) and its sequelae have focused on school-age children in the poorest socioeconomic areas; however, it is unclear whether this approach is optimal given the strong association with demographic risk factors other than deprivation, especially ethnicity. The aim of this study was to estimate the stratum-specific risk of ARF by key sociodemographic characteristics. We used hospitalization and disease notification data to identify new cases of ARF between 2010 and 2013, and used population count data from the 2013 New Zealand Census as our denominator. Poisson logistic regression methods were used to estimate stratum-specific risk of ARF development. The likelihood of ARF development varied considerably by age, ethnicity and deprivation strata: while risk was greatest in Māori and Pacific children aged 10-14 years residing in the most extreme deprivation, both of these ethnic groups experienced elevated risk across a wide age range and across deprivation levels. Interventions that target populations based on deprivation will include the highest-risk strata, but they will also (a) include groups with very low risk of ARF, such as non-Māori/non-Pacific children; and (b) exclude groups with moderate risk of ARF, such as Māori and Pacific individuals living outside high deprivation areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.